Covimectin 12 mg

Covimectin 12 mg – Product Description

Covimectin 12 mg is a highly effective oral antiparasitic medication containing Ivermectin, widely used for the treatment and management of various internal and external parasitic infections. Belonging to the class of anthelmintics, Covimectin 12 mg provides broad-spectrum activity against intestinal worms, scabies, lice, and other ectoparasitic infestations. Its safety, rapid action, and proven efficacy make it a preferred choice for healthcare professionals worldwide for both adults and children under medical supervision.

Parasitic infections can significantly affect overall health and well-being, causing symptoms such as abdominal pain, diarrhea, fatigue, skin irritation, and nutritional deficiencies. Covimectin 12 mg works by targeting the nervous system of parasites, resulting in paralysis and death. Once immobilized, the parasites are naturally expelled from the body, restoring digestive health and improving overall wellness. This dosage is particularly suitable for moderate to severe infestations or in cases where a stronger dose is needed for effective parasite clearance.

Mechanism of Action

Covimectin 12 mg exerts its antiparasitic effects by selectively binding to glutamate-gated chloride channels in the nerve and muscle cells of parasites. This binding increases chloride ion permeability, causing hyperpolarization of the cells, paralysis, and eventual death of the parasites. Ivermectin has minimal penetration into the human central nervous system at therapeutic doses, making it safe when used as prescribed.

By paralyzing the parasites, Covimectin 12 mg prevents further damage and allows the body’s immune system to remove the immobilized parasites. Its systemic absorption ensures effectiveness against parasites not only in the intestines but also in other tissues where they may reside, providing comprehensive treatment in a single dose or short course.

Uses and Indications

Covimectin 12 mg is indicated for the treatment of a wide range of parasitic conditions, including:

• Intestinal worms, including roundworms, whipworms, threadworms, and other gastrointestinal parasites

• Scabies and other skin infestations caused by mites

• Head lice and other external parasitic infestations

• Onchocerciasis (river blindness) in endemic regions

• Preventive therapy in areas with high prevalence of parasitic infections

This high-strength oral tablet is particularly useful for patients who require rapid and effective parasite control or when lower doses have not achieved adequate results.

Dosage and Administration

Covimectin 12 mg should be taken exactly as prescribed by a healthcare professional. It is administered orally, with or without food. Dosage depends on the type of infection, the patient’s body weight, and overall health condition. Strict adherence to the prescribed regimen is crucial for optimal outcomes. Self-medication or dose adjustment without medical guidance can reduce effectiveness and increase the risk of side effects.

Safety and Precautions

Covimectin 12 mg is generally well tolerated. Common side effects may include mild nausea, diarrhea, dizziness, or headache. Severe adverse effects, such as allergic reactions or neurological symptoms, are rare but may occur in patients with high parasite loads or pre-existing medical conditions.

Patients with liver or kidney disorders, neurological conditions, or known hypersensitivity to Ivermectin should consult a doctor before using Covimectin 12 mg. Pregnant or breastfeeding women should only use this medication under strict medical supervision. Maintaining hygiene and preventive measures is important to avoid reinfection after treatment.

Storage Guidelines

Store Covimectin 12 mg tablets in a cool, dry place, away from direct sunlight, heat, and moisture. Keep the tablets in their original packaging and out of reach of children. Do not use beyond the expiration date printed on the label.

Additional Reference

For more detailed information on Ivermectin and its clinical applications, visit the World Health Organization (WHO) guidance:
https://www.who.int/teams/control-of-neglected-tropical-diseases/ivermectin